RT Book, Section A1 Prasad, Ramakrishna A1 Pillala, Praneeth A1 Liu,, Gordon A2 South-Paul, Jeannette E. A2 Matheny, Samuel C. A2 Lewis, Evelyn L. SR Print(0) ID 1173718622 T1 HIV Primary Care T2 CURRENT Diagnosis & Treatment: Family Medicine, 5e YR 2020 FD 2020 PB McGraw Hill PP New York, NY SN 9781260134896 LK accessmedicine.mhmedical.com/content.aspx?aid=1173718622 RD 2024/04/25 AB ESSENTIALS OF DIAGNOSIS AND TREATMENTIn the United States of America, the Human Immunodeficiency Virus (HIV) Laboratory Diagnostic Testing Algorithm (Centers for Disease Control and Prevention [CDC]) is used. This algorithm recommends initial testing with an HIV-1/2 antigen/antibody immunoassay (step 1). A single HIV test result cannot provide a definitive HIV-positive diagnosis. If the initial test is reactive, specimens should be tested with an HIV-1/HIV-2 antibody differentiation assay (step 2). In case of negativeorindeterminate results at step 2, HIV-1 nucleic acid amplification test (NAAT) is recommended. Globally, the World Health Organization (WHO)–recommended testing algorithms are widely used. The HIV prevalence of the population—either high (≥5%) HIV prevalence or low (<5%) HIV prevalence—is used to inform national HIV testing algorithms (which may vary from country to country).HIV RNA level (viral load) should be ideally used to monitor response to antiretroviral therapy. In resource-limited settings where access to viral load monitoring is limited, CD4 measurements along with clinical assessments may be used to monitor therapy.Absolute CD4 lymphocyte count is widely used for staging HIV disease. Acquired immunodeficiency syndrome (AIDS) is defined as a CD4 <200 cells/mm3. AIDS represents advanced HIV disease that is associated with opportunistic infections or malignancy in the absence of treatment.Although HIV infection cannot be cured currently, antiretroviral drugs are highly effective in suppressing viral replication and enable people living with HIV to enjoy healthy, long, and productive lives. Additionally, they prevent transmission to others.One of the landmark recent advances with the potential to combat stigma has been the recognition of “U = U” (undetectable = untransmittable). There is now evidence-based confirmation that the risk of HIV transmission from people living with HIV, who are on antiretroviral therapy (ART) and have achieved an undetectable viral load in their blood for at least 6 months, is negligible.